GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » ROE % Adjusted to Book Value

Elixxer (Elixxer) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Elixxer ROE % Adjusted to Book Value?

Elixxer's ROE % for the quarter that ended in Sep. 2023 was 0.00%. Elixxer's PB Ratio for the quarter that ended in Sep. 2023 was N/A. Elixxer's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was N/A.


Elixxer ROE % Adjusted to Book Value Historical Data

The historical data trend for Elixxer's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer ROE % Adjusted to Book Value Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -47.20 -58.18 -29.82 -

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity - - - -

Competitive Comparison of Elixxer's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixxer's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Elixxer's ROE % Adjusted to Book Value falls into.



Elixxer ROE % Adjusted to Book Value Calculation

Elixxer's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-856.13% / N/A
=N/A

Elixxer's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixxer ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Elixxer's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (Elixxer) Business Description

Traded in Other Exchanges
N/A
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Elixxer (Elixxer) Headlines

From GuruFocus

Elixxer Ltd. Provides Update on Proposed Private Placement

By Marketwired Marketwired 10-09-2020

Elixxer Ltd. Provides Corporate Update

By Marketwired Marketwired 02-26-2021

Little Green Pharma Continues Record Breaking Sales Growth

By Marketwired Marketwired 05-28-2020

Elixxer Ltd. Provides Update on Proposed Private Placement

By GlobeNewswire GlobeNewswire 10-08-2020